Blocking or adjacent IP in the same technical area, owned by third parties. Not affiliated with this organization.
AU2024264609A1
AU2024264609A1 - Retinal pigment epithelium cell compositions - Google Patents AU2024264609A1 - Retinal pigment epithelium cell compositions - Google Patents Retinal pigment epithelium cell compositions Download PDF Info Publication number…
WO2023019227A1
WO2023019227A1 - Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions - Google Patents WO2023019227A1 - Genetically modified cells for allogeneic cell therapy to reduce complement-media…
US20240010988A1
US20240010988A1 - Genetically modified primary cells for allogeneic cell therapy - Google Patents US20240010988A1 - Genetically modified primary cells for allogeneic cell therapy - Google Patents Genetically modified primary cells for allog…
US20230027004A1
US20230027004A1 - Closed-system and method for autologous and allogeneic cell therapy manufacturing - Google Patents US20230027004A1 - Closed-system and method for autologous and allogeneic cell therapy manufacturing - Google Patents Closed…
WO2020023561A1
WO2020023561A1 - Use of anti-cd5 antibody drug conjugate (adc) in allogeneic cell therapy - Google Patents WO2020023561A1 - Use of anti-cd5 antibody drug conjugate (adc) in allogeneic cell therapy - Google Patents Use of anti-cd5 antibody d…
US7435592B2
US7435592B2 - Compositions for allogeneic cell therapy - Google Patents US7435592B2 - Compositions for allogeneic cell therapy - Google Patents Compositions for allogeneic cell therapy Download PDF Info Publication number US7435592B2 US7435…
WO2023019229A1
WO2023019229A1 - Genetically modified primary cells for allogeneic cell therapy - Google Patents WO2023019229A1 - Genetically modified primary cells for allogeneic cell therapy - Google Patents Genetically modified primary cells for allogen…
WO2020222176A1
WO2020222176A1 - Allogeneic cell therapy of b cell malignancies using genetically engineered t cells targeting cd19 - Google Patents WO2020222176A1 - Allogeneic cell therapy of b cell malignancies using genetically engineered t cells target…
WO2005001074A1
WO2005001074A1 - Allogeneic cell therapy: mirror effect - Google Patents WO2005001074A1 - Allogeneic cell therapy: mirror effect - Google Patents Allogeneic cell therapy: mirror effect Download PDF Info Publication number WO2005001074A1 WO2…
WO2023019226A1
WO2023019226A1 - Genetically modified cells for allogeneic cell therapy - Google Patents WO2023019226A1 - Genetically modified cells for allogeneic cell therapy - Google Patents Genetically modified cells for allogeneic cell therapy Downloa…
US8273377B2
US8273377B2 - Method for allogeneic cell therapy - Google Patents US8273377B2 - Method for allogeneic cell therapy - Google Patents Method for allogeneic cell therapy Download PDF Info Publication number US8273377B2 US8273377B2 US12/869,490…
WO2014080991A1
WO2014080991A1 - 糖タンパク質の糖鎖を遊離させる活性を有する酵素およびその製造方法、該酵素を用いる糖鎖の遊離方法 - Google Patents WO2014080991A1 - 糖タンパク質の糖鎖を遊離させる活性を有する酵素およびその製造方法、該酵素を用いる糖鎖の遊離方法 - Google Patents 糖タンパク質の糖鎖を遊離させる活性を有する酵素およびその製造方法、該酵素を用いる糖鎖の遊離方法 Download PDF Info Publicatio…
WO2009131223A1
WO2009131223A1 - Dnaメチル化分析方法 - Google Patents WO2009131223A1 - Dnaメチル化分析方法 - Google Patents Dnaメチル化分析方法 Download PDF Info Publication number WO2009131223A1 WO2009131223A1 PCT/JP2009/058199 JP2009058199W WO2009131223A1 WO 2009131223 A1 WO200…
WO2014080991A1
WO2014080991A1 - Enzyme having activity for releasing glycoprotein sugar chains and method for producing same, and method for releasing sugar chains using said enzyme - Google Patents WO2014080991A1 - Enzyme having activity for releasing gl…
WO2022045723A1
WO2022045723A1 - Composition favorisant la différenciation de cellules souches neurales en neurones dopaminergiques - Google Patents WO2022045723A1 - Composition favorisant la différenciation de cellules souches neurales en neurones dopamin…
EP2581443A2
EP2581443A2 - Method for differentiating human neural progenitor cells into dopaminergic neurons, and medium for differentiation thereof - Google Patents EP2581443A2 - Method for differentiating human neural progenitor cells into dopaminerg…
US10137199B2
US10137199B2 - Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione - Google Patents US10137199B2 - Thiolated hyaluronan-based hydrogels cross-linked using oxidized glutathione - Google Patents Thiolated hyaluronan-b…
WO2013065914A1
WO2013065914A1 - 낭성구조물로부터 망막색소상피세포로의 분화 유도 방법 - Google Patents WO2013065914A1 - 낭성구조물로부터 망막색소상피세포로의 분화 유도 방법 - Google Patents 낭성구조물로부터 망막색소상피세포로의 분화 유도 방법 Download PDF Info Publication number WO2013065914A1 WO2013065914A1 PCT/KR2012/002400…
US10077424B2
US10077424B2 - Methods of producing RPE cells and compositions of RPE cells - Google Patents US10077424B2 - Methods of producing RPE cells and compositions of RPE cells - Google Patents Methods of producing RPE cells and compositions of RPE…
US10485829B2
US10485829B2 - Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells - Google Patents US10485829B2 - Methods of producing human RPE cells and pharmaceutical preparations of human RPE cells - Google Patents…
WO2013184809A1
WO2013184809A1 - Methods and compositions for the rapid production of retinal pigmented epithelial cells from pluripotent cells - Google Patents WO2013184809A1 - Methods and compositions for the rapid production of retinal pigmented epithel…
EP3240890B1
EP3240890B1 - Assessing retinal pigment epithelial cell populations - Google Patents EP3240890B1 - Assessing retinal pigment epithelial cell populations - Google Patents Assessing retinal pigment epithelial cell populations Download PDF Inf…
US10246682B2
US10246682B2 - Methods of culturing retinal pigmented epithelium cells, including Xeno-free production, RPE enrichment, and cryopreservation - Google Patents US10246682B2 - Methods of culturing retinal pigmented epithelium cells, including…
CN113874083A
CN113874083A - 抗-tnfr2抗体及其用途 - Google Patents CN113874083A - 抗-tnfr2抗体及其用途 - Google Patents 抗-tnfr2抗体及其用途 Download PDF Info Publication number CN113874083A CN113874083A CN202080032324.7A CN202080032324A CN113874083A CN 113874083 A CN1138740…
US20220281990A1
US20220281990A1 - Anti-tnfr2 antibodies and uses thereof - Google Patents US20220281990A1 - Anti-tnfr2 antibodies and uses thereof - Google Patents Anti-tnfr2 antibodies and uses thereof Download PDF Info Publication number US20220281990A1…
WO2020180712A1
WO2020180712A1 - Anti-tnfr2 antibodies and uses thereof - Google Patents WO2020180712A1 - Anti-tnfr2 antibodies and uses thereof - Google Patents Anti-tnfr2 antibodies and uses thereof Download PDF Info Publication number WO2020180712A1 WO2…
KR20210106966A
KR20210106966A - Neural stem cells derived from 3D brain organoid and use thereof - Google Patents KR20210106966A - Neural stem cells derived from 3D brain organoid and use thereof - Google Patents Neural stem cells derived from 3D brain or…
EP3972617A4
EP3972617A4 - AUTOLOGOUS CELLULAR SUBSTITUTION THERAPY FOR PARKINSON'S DISEASE - Google Patents EP3972617A4 - AUTOLOGOUS CELLULAR SUBSTITUTION THERAPY FOR PARKINSON'S DISEASE - Google Patents AUTOLOGOUS CELLULAR SUBSTITUTION THERAPY…
WO2024233788A2
WO2024233788A2 - Intra-striatal co-transplantation of autologous treg and mda cells in parkinson's disease cell therapy - Google Patents WO2024233788A2 - Intra-striatal co-transplantation of autologous treg and mda cells in parkinson…
WO2020237104A1
WO2020237104A1 - Autologous cell replacement therapy for parkinson's disease - Google Patents WO2020237104A1 - Autologous cell replacement therapy for parkinson's disease - Google Patents Autologous cell replacement therapy for park…